Retroelements in human disease

Gene

Volumn 518, Issue 2, 2013, Pages 231-241

  Kaer, Kristel ^a   Speek, Mart ^a  

^a TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

Author keywords

Alu; Cryptic splice sites; Exonization; L1; SVA; Transcriptional interference

Indexed keywords

6 PYRUVOYLTETRAHYDROPTERIN SYNTHASE; APC PROTEIN; BETA GLUCURONIDASE; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; BRUTON TYROSINE KINASE; CALCIUM SENSING RECEPTOR; CD40 LIGAND; CHOLINESTERASE; COLLAGEN TYPE 4; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA; DYSTROPHIN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FUKUTIN; GLYCEROL KINASE; MISMATCH REPAIR PROTEIN PMS2; NEUROFIBROMIN; ORNITHINE OXOACID AMINOTRANSFERASE; PORPHOBILINOGEN DEAMINASE; PROGESTERONE RECEPTOR; PROTEIN MSH2; RNA; S6 KINASE;

ACHOLINESTERASEMIA; ACROCEPHALOSYNDACTYLY; ACUTE INTERMITTENT PORPHYRIA; ALSTROM SYNDROME; ALTERNATIVE RNA SPLICING; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOSOMAL DOMINANT OPTIC ATROPHY; BETA THALASSEMIA; BREAST CANCER; CHANARIN DORFMAN SYNDROME; CHOROID GYRATE ATROPHY; CHOROIDEREMIA; CHRONIC GRANULOMATOUS DISEASE; CHRONIC NONSPHEROCYTIC HEMOLYTIC ANEMIA; COFFIN LOWRY SYNDROME; COLON CANCER; CONGENITAL CATARACT FACIAL DYSMORPHISM NEUROPATHY SYNDROME; COPY NUMBER VARIATION; CYSTIC FIBROSIS; DENT DISEASE; DISEASE PREDISPOSITION; DUCHENNE MUSCULAR DYSTROPHY; ELLIPTOCYTOSIS; EXON; EXON SKIPPING; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GENE INSERTION; GENETIC DISORDER; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; GLYCEROL KINASE DEFICIENCY; HEMOPHILIA A; HEMOPHILIA B; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; HUMAN GENOME; HYPER IMMUNOGLOBULIN M SYNDROME; INTRON; MENKES SYNDROME; MOWAT WILSON SYNDROME; MUCOLIPIDOSIS TYPE 2; MUCOPOLYSACCHARIDOSIS TYPE 7; MUTAGENESIS; MUTAGENIC ACTIVITY; NEUROFIBROMATOSIS; NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; RETINA GYRATE ATROPHY; RETINITIS PIGMENTOSA; RETROPOSON; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TETRAHYDROBIOPTERIN DEFICIENCY; WALKER WARBURG SYNDROME; X LINKED AGAMMAGLOBULINEMIA; X LINKED DYSTONIA PARKINSONISM;

ALTERNATIVE SPLICING; GENE EXPRESSION; GENETIC DISEASES, INBORN; GENETIC VARIATION; GENOME, HUMAN; HUMANS; MUTATION; POLYADENYLATION; PROMOTER REGIONS, GENETIC; RETROELEMENTS; RNA SPLICE SITES; RNA SPLICING; TRANSCRIPTION, GENETIC;

EID: 84875377539     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.01.008     Document Type: Review

References (113)

1. Abdelhak S., et al. Clustering of mutations responsible for branchio-oto-renal (BOR) syndrome in the eyes absent homologous region (eyaHR) of EYA1. Hum. Mol. Genet. 1997, 6:2247-2255.
2. Akman H.O., et al. Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene. Neuromuscul. Disord. 2010, 20:397-402.
3. Apoil P.A., Kuhlein E., Robert A., Rubie H., Blancher A. HIGM syndrome caused by insertion of an AluYb8 element in exon 1 of the CD40LG gene. Immunogenetics 2007, 59:17-23.
4. Awano H., Malueka R.G., Yagi M., Okizuka Y., Takeshima Y., Matsuo M. Contemporary retrotransposition of a novel non-coding gene induces exon-skipping in dystrophin mRNA. J. Hum. Genet. 2010, 55:785-790.
5. Baillie J.K., et al. Somatic retrotransposition alters the genetic landscape of the human brain. Nature 2011, 479:534-537.
6. Beck C.R., et al. LINE-1 retrotransposition activity in human genomes. Cell 2010, 141:1159-1170.
7. Beck C.R., Garcia-Perez J.L., Badge R.M., Moran J.V. LINE-1 elements in structural variation and disease. Annu. Rev. Genomics Hum. Genet. 2011, 12:187-215.
8. Belancio V.P., Hedges D.J., Deininger P. LINE-1 RNA splicing and influences on mammalian gene expression. Nucleic Acids Res. 2006, 34:1512-1521.
9. Belancio V.P., Hedges D.J., Deininger P. Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res. 2008, 18:343-358.
10. Bernard V., Minnerop M., Burk K., Kreuz F., Gillessen-Kaesbach G., Zuhlke C. Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2. BMC Med. Genet. 2009, 10:87.
11. Bochukova E.G., et al. Rare mutations of FGFR2 causing Apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily. Hum. Mutat. 2009, 30:204-211.
12. Boissinot S., Entezam A., Furano A.V. Selection against deleterious LINE-1-containing loci in the human lineage. Mol. Biol. Evol. 2001, 18:926-935.
13. Bouchet C., et al. Detection of an Alu insertion in the POMT1 gene from three French Walker Warburg syndrome families. Mol. Genet. Metab. 2007, 90:93-96.
14. Brouha B., et al. Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am. J. Hum. Genet. 2002, 71:327-336.
15. Brouha B., et al. Hot L1s account for the bulk of retrotransposition in the human population. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:5280-5285.
16. Callinan P.A., Batzer M.A. Retrotransposable elements and human disease. Genome Dyn. 2006, 1:104-115.
17. Chen J.M., et al. Detection of two Alu insertions in the CFTR gene. J. Cyst. Fibros. 2008, 7:37-43.
18. Claverie-Martin F., Gonzalez-Acosta H., Flores C., Anton-Gamero M., Garcia-Nieto V. De novo insertion of an Alu sequence in the coding region of the CLCN5 gene results in Dent's disease. Hum. Genet. 2003, 113:480-485.
19. Claverie-Martin F., Flores C., Anton-Gamero M., Gonzalez-Acosta H., Garcia-Nieto V. The Alu insertion in the CLCN5 gene of a patient with Dent's disease leads to exon 11 skipping. J. Hum. Genet. 2005, 50:370-374.
20. Conley M.E., Partain J.D., Norland S.M., Shurtleff S.A., Kazazian H.H. Two independent retrotransposon insertions at the same site within the coding region of BTK. Hum. Mutat. 2005, 25:324-325.
21. Coufal N.G., et al. L1 retrotransposition in human neural progenitor cells. Nature 2009, 460:1127-1131.
22. den Hollander A.I., et al. Mutations in a human homologue of Drosophila crumbs cause retinitis pigmentosa (RP12). Nat. Genet. 1999, 23:217-221.
23. Economou-Pachnis A., Tsichlis P.N. Insertion of an Alu SINE in the human homologue of the Mlvi-2 locus. Nucleic Acids Res. 1985, 13:8379-8387.
24. Eperon L.P., Graham I.R., Griffiths A.D., Eperon I.C. Effects of RNA secondary structure on alternative splicing of pre-mRNA: is folding limited to a region behind the transcribing RNA polymerase?. Cell 1988, 54:393-401.
25. Evrony G.D., et al. Single-neuron sequencing analysis of l1 retrotransposition and somatic mutation in the human brain. Cell 2012, 151:483-496.
26. Ewing A.D., Kazazian H.H. High-throughput sequencing reveals extensive variation in human-specific L1 content in individual human genomes. Genome Res. 2010, 20:1262-1270.
27. Feng Q., Moran J.V., Kazazian H.H., Boeke J.D. Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell 1996, 87:905-916.
28. Gallus G.N., et al. Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy. Mol. Vis. 2010, 16:178-183.
29. Ganguly A., Dunbar T., Chen P., Godmilow L., Ganguly T. Exon skipping caused by an intronic insertion of a young Alu Yb9 element leads to severe hemophilia A. Hum. Genet. 2003, 113:348-352.
30. Green P.M., Bagnall R.D., Waseem N.H., Giannelli F. Haemophilia A mutations in the UK: results of screening one-third of the population. Br. J. Haematol. 2008, 143:115-128.
31. Grover D., Kannan K., Brahmachari S.K., Mukerji M. ALU-ring elements in the primate genomes. Genetica 2005, 124:273-289.
32. Gu Y., et al. The first reported case of Menkes disease caused by an Alu insertion mutation. Brain Dev. 2007, 29:105-108.
33. Halling K.C., et al. Hereditary desmoid disease in a family with a germline Alu I repeat mutation of the APC gene. Hum. Hered. 1999, 49:97-102.
34. Han J.S., Szak S.T., Boeke J.D. Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes. Nature 2004, 429:268-274.
35. Hancks D.C., Kazazian H.H. SVA retrotransposons: evolution and genetic instability. Semin. Cancer Biol. 2010, 20:234-245.
36. Hancks D.C., Kazazian H.H. Active human retrotransposons: variation and disease. Curr. Opin. Genet. Dev. 2012, 22:191-203.
37. Hancks D.C., Ewing A.D., Chen J.E., Tokunaga K., Kazazian H.H. Exon-trapping mediated by the human retrotransposon SVA. Genome Res. 2009, 19:1983-1991.
38. Hancks D.C., Goodier J.L., Mandal P.K., Cheung L.E., Kazazian H.H. Retrotransposition of marked SVA elements by human L1s in cultured cells. Hum. Mol. Genet. 2011, 20:3386-3400.
39. Hassoun H., et al. A novel mobile element inserted in the alpha spectrin gene: spectrin dayton. A truncated alpha spectrin associated with hereditary elliptocytosis. J. Clin. Invest. 1994, 94:643-648.
40. Hoffman B.E., Grabowski P.J. U1 snRNP targets an essential splicing factor, U2AF65, to the 3' splice site by a network of interactions spanning the exon. Genes Dev. 1992, 6:2554-2568.
41. Hohjoh H., Singer M.F. Cytoplasmic ribonucleoprotein complexes containing human LINE-1 protein and RNA. EMBO J. 1996, 15:630-639.
42. Holmes S.E., Dombroski B.A., Krebs C.M., Boehm C.D., Kazazian H.H. A new retrotransposable human L1 element from the LRE2 locus on chromosome 1q produces a chimaeric insertion. Nat. Genet. 1994, 7:143-148.
43. Huang C.R., et al. Mobile interspersed repeats are major structural variants in the human genome. Cell 2010, 141:1171-1182.
44. Ishihara N., et al. Clinical and molecular analysis of Mowat-Wilson syndrome associated with ZFHX1B mutations and deletions at 2q22-q24.1. J. Med. Genet. 2004, 41:387-393.
45. Janicic N., Pausova Z., Cole D.E., Hendy G.N. Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am. J. Hum. Genet. 1995, 56:880-886.
46. Kaer K., Branovets J., Hallikma A., Nigumann P., Speek M. Intronic L1 retrotransposons and nested genes cause transcriptional interference by inducing intron retention, exonization and cryptic polyadenylation. PLoS One 2011, 6:e26099.
47. Kale S.P., Moore L., Deininger P.L., Roy-Engel A.M. Heavy metals stimulate human LINE-1 retrotransposition. Int. J. Environ. Res. Public Health 2005, 2:14-23.
48. Kano H., et al. L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev. 2009, 23:1303-1312.
49. Karlskov-Mortensen, et al. Exonization of a LINE1 fragment implicated in X-linked hypohidrotic ectodermal dysplasia in cattle. Anim. Genet. 2011, 42:578-584.
50. Kazazian H.H., Wong C., Youssoufian H., Scott A.F., Phillips D.G., Antonarakis S.E. Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature 1988, 332:164-166.
51. Khan H., Smit A., Boissinot S. Molecular evolution and tempo of amplification of human LINE-1 retrotransposons since the origin of primates. Genome Res. 2006, 16:78-87.
52. Kimberland M.L., Divoky V., Prchal J., Schwahn U., Berger W., Kazazian H.H. Full-length human L1 insertions retain the capacity for high frequency retrotransposition in cultured cells. Hum. Mol. Genet. 1999, 8:1557-1560.
53. Kloor M., et al. A large MSH2 Alu insertion mutation causes HNPCC in a German kindred. Hum. Genet. 2004, 115:432-438.
54. Knebelmann B., et al. Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum. Mol. Genet. 1995, 4:675-679.
55. Kobayashi K., et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998, 394:388-392.
56. Kondo-Iida E., et al. Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD). Hum. Mol. Genet. 1999, 8:2303-2309.
57. Kornblihtt A.R. Chromatin, transcript elongation and alternative splicing. Nat. Struct. Mol. Biol. 2006, 13:5-7.
58. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
59. Lev-Maor G., Sorek R., Shomron N., Ast G. The birth of an alternatively spliced exon: 3' splice-site selection in Alu exons. Science 2003, 300:1288-1291.
60. Li X., et al. Frequency of recent retrotransposition events in the human factor IX gene. Hum. Mutat. 2001, 17:511-519.
61. Machado P.M., et al. Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes. J. Clin. Oncol. 2007, 25:2027-2034.
62. Makino S., et al. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am. J. Hum. Genet. 2007, 80:393-406.
63. Manco L., Relvas L., Silva Pinto C., Pereira J., Almeida A.B., Ribeiro M.L. Molecular characterization of five Portuguese patients with pyrimidine 5'-nucleotidase deficient hemolytic anemia showing three new P5'N-I mutations. Haematologica 2006, 91:266-267.
64. Maquat L.E. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat. Rev. Mol. Cell Biol. 2004, 5:89-99.
65. Martinez-Garay I., et al. Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome. Clin. Genet. 2003, 64:491-496.
66. Mathias S.L., Scott A.F., Kazazian H.H., Boeke J.D., Gabriel A. Reverse transcriptase encoded by a human transposable element. Science 1991, 254:1808-1810.
67. Meili D., et al. Disease-causing mutations improving the branch site and polypyrimidine tract: pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail. Hum. Mutat. 2009, 30:823-831.
68. Meischl C., Boer M., Ahlin A., Roos D. A new exon created by intronic insertion of a rearranged LINE-1 element as the cause of chronic granulomatous disease. Eur. J. Hum. Genet. 2000, 8:697-703.
69. Miki Y., et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. Cancer Res. 1992, 52:643-645.
70. Miki Y., Katagiri T., Kasumi F., Yoshimoto T., Nakamura Y. Mutation analysis in the BRCA2 gene in primary breast cancers. Nat. Genet. 1996, 13:245-247.
71. Mitchell G.A., et al. Splice-mediated insertion of an Alu sequence inactivates ornithine delta-aminotransferase: a role for Alu elements in human mutation. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:815-819.
72. Mukherjee S., Mukhopadhyay A., Banerjee D., Chandak G.R., Ray K. Molecular pathology of haemophilia B: identification of five novel mutations including a LINE 1 insertion in Indian patients. Haemophilia 2004, 10:259-263.
73. Muratani K., et al. Inactivation of the cholinesterase gene by Alu insertion: possible mechanism for human gene transposition. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:11315-11319.
74. Mustajoki S., Ahola H., Mustajoki P., Kauppinen R. Insertion of Alu element responsible for acute intermittent porphyria. Hum. Mutat. 1999, 13:431-438.
75. Narita N., et al. Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J. Clin. Invest. 1993, 91:1862-1867.
76. Oldridge M., et al. De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome. Am. J. Hum. Genet. 1999, 64:446-461.
77. Ostertag E.M., Kazazian H.H. Biology of mammalian L1 retrotransposons. Annu. Rev. Genet. 2001, 35:501-538.
78. Perepelitsa-Belancio V., Deininger P. RNA truncation by premature polyadenylation attenuates human mobile element activity. Nat. Genet. 2003, 35:363-366.
79. Robberson B.L., Cote G.J., Berget S.M. Exon definition may facilitate splice site selection in RNAs with multiple exons. Mol. Cell. Biol. 1990, 10:84-94.
80. Rohrer J., Minegishi Y., Richter D., Eguiguren J., Conley M.E. Unusual mutations in Btk: an insertion, a duplication, an inversion, and four large deletions. Clin. Immunol. 1999, 90:28-37.
81. Rowe S.M., et al. Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res. 1995, 55:2743-2745.
82. Samuelov L., Fuchs-Telem D., Sarig O., Sprecher E. An exceptional mutational event leading to Chanarin-Dorfman syndrome in a large consanguineous family. Br. J. Dermatol. 2011, 164:1390-1392.
83. Schwahn U., et al. Positional cloning of the gene for X-linked retinitis pigmentosa 2. Nat. Genet. 1998, 19:327-332.
84. Shearwin K.E., Callen B.P., Egan J.B. Transcriptional interference-a crash course. Trends Genet. 2005, 21:339-345.
85. Singer T., McConnell M.J., Marchetto M.C., Coufal N.G., Gage F.H. LINE-1 retrotransposons: mediators of somatic variation in neuronal genomes?. Trends Neurosci. 2010, 33:345-354.
86. Sironen A., Vilkki J., Bendixen C., Thomsen B. Infertile Finnish Yorkshire boars carry a full-length LINE-1 retrotransposon within the KPL2 gene. Mol. Genet. Genomics 2007, 278:385-391.
87. Smit A.F. Interspersed repeats and other mementos of transposable elements in mammalian genomes. Curr. Opin. Genet. Dev. 1999, 9:657-663.
88. Sobrier M.L., et al. Alu-element insertion in the homeodomain of HESX1 and aplasia of the anterior pituitary. Hum. Mutat. 2005, 25:503.
89. Solyom S., et al. Pathogenic orphan transduction created by a nonreference LINE-1 retrotransposon. Hum. Mutat. 2012, 33:369-371.
90. Sorek R., Ast G., Graur D. Alu-containing exons are alternatively spliced. Genome Res. 2002, 12:1060-1067.
91. Speek M. Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol. Cell. Biol. 2001, 21:1973-1985.
92. Stewart C., et al. A comprehensive map of mobile element insertion polymorphisms in humans. PLoS Genet. 2011, 7:e1002236.
93. Swergold G.D. Identification, characterization, and cell specificity of a human LINE-1 promoter. Mol. Cell. Biol. 1990, 10:6718-6729.
94. Tanaka A., et al. Ionising irradiation alters the dynamics of human long interspersed nuclear elements 1 (LINE1) retrotransposon. Mutagenesis 2012, 27:599-607.
95. Taniguchi-Ikeda M., et al. Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 2011, 478:127-131.
96. Tappino B., Regis S., Corsolini F., Filocamo M. An Alu insertion in compound heterozygosity with a microduplication in GNPTAB gene underlies Mucolipidosis II. Mol. Genet. Metab. 2008, 93:129-133.
97. Taskesen M., et al. Novel Alu retrotransposon insertion leading to Alstrom syndrome. Hum. Genet. 2012, 131:407-413.
98. Teugels E., De Brakeleer S., Goelen G., Lissens W., Sermijn E., De Greve J. De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes. Hum. Mutat. 2005, 26:284.
99. Tighe P.J., Stevens S.E., Dempsey S., Le Deist F., Rieux-Laucat F., Edgar J.D. Inactivation of the Fas gene by Alu insertion: retrotransposition in an intron causing splicing variation and autoimmune lymphoproliferative syndrome. Genes Immun. 2002, 3(Suppl. 1):S66-S70.
100. Tucker B.A., et al. Exome sequencing and analysis of induced pluripotent stem cells identify the cilia-related gene male germ cell-associated kinase (MAK) as a cause of retinitis pigmentosa. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:E569-E576.
101. Ullu E., Tschudi C. Alu sequences are processed 7SL RNA genes. Nature 1984, 312:171-172.
102. van den Hurk J.A., et al. Novel types of mutation in the choroideremia (CHM) gene: a full-length L1 insertion and an intronic mutation activating a cryptic exon. Hum. Genet. 2003, 113:268-275.
103. van den Hurk J.A., et al. L1 retrotransposition can occur early in human embryonic development. Hum. Mol. Genet. 2007, 16:1587-1592.
104. van der Klift H.M., Tops C.M., Hes F.J., Devilee P., Wijnen J.T. Insertion of an SVA element, a nonautonomous retrotransposon, in PMS2 intron 7 as a novel cause of Lynch syndrome. Hum. Mutat. 2012, 33:1051-1055.
105. Varon R., et al. Partial deficiency of the C-terminal-domain phosphatase of RNA polymerase II is associated with congenital cataracts facial dysmorphism neuropathy syndrome. Nat. Genet. 2003, 35:185-189.
106. Vervoort R., Gitzelmann R., Lissens W., Liebaers I. A mutation (IVS8+0.6kbdelTC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human beta-glucuronidase gene. Hum. Genet. 1998, 103:686-693.
107. Wallace M.R., Andersen L.B., Saulino A.M., Gregory P.E., Glover T.W., Collins F.S. A de novo Alu insertion results in neurofibromatosis type 1. Nature 1991, 353:864-866.
108. Wilund K.R., et al. Molecular mechanisms of autosomal recessive hypercholesterolemia. Hum. Mol. Genet. 2002, 11:3019-3030.
109. Wimmer K., Callens T., Wernstedt A., Messiaen L. The NF1 gene contains hotspots for L1 endonuclease-dependent de novo insertion. PLoS Genet 2011, 7:e1002371.
110. Wulff K., Bykowska K., Lopaciuk S., Herrmann F.H. Molecular analysis of hemophilia B in Poland: 12 novel mutations of the factor IX gene. Acta Biochim. Pol. 1999, 46:721-726.
111. Xing J., et al. Mobile elements create structural variation: analysis of a complete human genome. Genome Res. 2009, 19:1516-1526.
112. Yoshida K., Nakamura A., Yazaki M., Ikeda S., Takeda S. Insertional mutation by transposable element, L1, in the DMD gene results in X-linked dilated cardiomyopathy. Hum. Mol. Genet. 1998, 7:1129-1132.
113. Zhang Y., et al. AluY insertion (IVS4-52ins316alu) in the glycerol kinase gene from an individual with benign glycerol kinase deficiency. Hum. Mutat. 2000, 15:316-323.